JACC Specialty Journals - podcast cover

JACC Specialty Journals

American College of Cardiologywww.jacc.org
In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

JACC Asia - August 1, 2024 Issue Summary

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman highlights key studies from the September 2024 issue, including groundbreaking research on the interplay between cardiometabolic disorders and depression, gender disparities in interventional cardiology, and the efficacy of new treatments for hypertension. The podcast also covers advancements in image-guided angioplasty, emphasizing the importance of integrated care and innovative approaches in cardiovascular medicine.

Sep 03, 202414 min

JACC Asia - Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman reviews a pivotal study comparing the angiotensin receptor neprilysin inhibitor sacubitril alisarmin with olmesartan for treating primary hypertension in Chinese patients. The trial found sacubitril alisarmin to be more effective in reducing blood pressure and well-tolerated, suggesting its potential as a new option for hypertension treatment, though further long-term studies are needed.

Sep 03, 20244 min
Hosted on Libsyn
For the best experience, listen in Metacast app for iOS or Android